NCT03844217View on ClinicalTrials.gov

Copeptin After an Oral Stimulation With Macimorelin in Healthy Volunteers

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 7, 2019

Primary Completion Date

July 16, 2019

Study Completion Date

July 16, 2019

Conditions
Polyuria-polydipsia Syndrome
Interventions
DRUG

Macimorelin 0.5mg/kg body weight

oral Macimorelin stimulation test with the dose of 0.5mg/kg body weight Macimorelin

DRUG

Macimorelin 0.75mg/kg body weight

oral Macimorelin stimulation test with the dose of 0.75mg/kg body weight Macimorelin

Trial Locations (1)

4031

University Hospital Basel Endocrinology, Diabetes and Metabolism, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT03844217 - Copeptin After an Oral Stimulation With Macimorelin in Healthy Volunteers | Biotech Hunter | Biotech Hunter